Inno Holdings Inc

This management proposal seeks stockholder approval to amend the Company’s Certificate of Formation to increase authorized common shares to 1,000,000,000 by creating 900,000,000 additional no-par-value shares. Management frames the amendment as a flexibility measure to support future equity financings, strategic transactions, and to provide shares for equity incentive plans, reducing the procedural delay and expense of calling a special stockholder meeting for additional authorization. The Board’s recommendation is driven by a desire to preserve optionality given the Company’s small outstanding float (8,413,224 shares as of the record date) and the stated plan to use shares for compensation and potential capital raises. Approving this proposal would expand the pool of authorized but unissued shares, which could be issued at the Board’s discretion subject to other corporate approvals and securities law requirements. The proposal includes no present commitments to issue the new shares and thus has both dilutive potential and strategic utility; investors should consider that future issuances could dilute existing ownership and earnings per share. From a governance perspective the increase concentrates discretion with the Board and could be used defensively in future hostile scenarios, although the Company states the purpose is commercial and operational flexibility. The vote requires a majority of shares entitled to vote; broker non-votes and abstentions are not counted as votes cast, which may affect the ease of approval depending on participation. In assessing the merits, a sophisticated analyst should weigh the Company’s near-term capital needs, historical use of equity for compensation, and any planned financings against the dilution risk and lack of specified issuance plans. If approved, the Company will effectuate the amendment by filing a Certificate of Amendment as attached in Annex A.

This management proposal grants the Board broad, discretionary authority to implement one or more reverse stock splits of the Company’s outstanding common shares at any time within two years, with aggregate split ratios between 1-for-2 and 1-for-4000. The Board explicitly ties the policy rationale to maintaining Nasdaq listing compliance (minimum $1.00 bid price) and avoiding delisting, noting Nasdaq rules can trigger delisting if deficiencies persist or if prior reverse splits preclude cure periods; thus the authority is intended as a tool to preserve access to public markets and investor liquidity. Management also argues that a higher per-share price might improve marketability by aligning with broker/institutional purchase policies, reduce perceived manipulation risk associated with low-priced stocks, and enable issuance flexibility for capital raising or equity-based compensation. The resolution delegates timing, ratio selection within the approved range, and fractional-share treatment entirely to the Board, including the ability to round or pay cash for fractional shares — a flexibility that expedites execution but increases governance discretion and potential uncertainty for small holders. Material risks include potential reduced liquidity from fewer shares outstanding, increased odd-lot holders and trading costs, possible negative investor perception of a reverse split as a distress signal, and the potential for the increased authorized-but-unissued shares to be used in anti-takeover manners. The proposal also outlines tax and accounting consequences, and it notes that reverse splits do not change proportional ownership but may affect market cap if price adjustment is not commensurate with share reduction. For analysts, the key considerations are the Company’s current bid price trajectory, Nasdaq deficiency risk, the Board’s past capital-raising needs and disclosures, and the broad ratio range (up to 1-for-4000) which could materially alter share count and float if exercised at the high end. Given these factors, the Board recommends approval as a defensive and strategic tool, but shareholders should weigh the immediate need for listing compliance against the dilution and liquidity trade-offs of potential subsequent issuances.

The proposal asks stockholders to approve the Company’s 2026 Omnibus Incentive Plan which reserves 1,680,000 shares for issuance through options, stock appreciation rights, restricted shares, restricted stock units, performance awards and other share- or cash-based awards. Management frames the Plan as a retention and compensation tool to align employees, non-employee directors and consultants with long-term shareholder value and to provide flexibility in designing performance- and time-based awards, including incentive stock options for employees. The Plan contains administratively typical features: Board/committee administration, the ability to set performance goals and vesting schedules, anti-dilution adjustments, change-in-control provisions, and limits on aggregate awards to non-employee directors ($350,000 default; up to $500,000 upon Administrator recommendation). Notably, the Plan includes an automatic annual share pool increase formula (the lesser of 20% of outstanding shares or up to 10,000,000 shares), which could materially expand the reserve over time and so is a vector for future dilution that investors should monitor. Tax and governance provisions are addressed, including Code Section 409A treatment, Section 162(m) considerations, and recoupment policy; the Plan will be effective upon Board approval but conditioned on subsequent stockholder ratification within 12 months. The Board’s rationale emphasizes recruiting and retention needs and standard market practices, while potential investor concerns center on dilution, the automatic replenishment feature, and the breadth of discretionary authority granted to the Administrator over award terms. For a sophisticated assessment, weigh current equity compensation outstanding, historical grant levels, executive ownership, and prospective hiring/capital plans against dilution forecasts under conservative and aggressive grant scenarios. The Board recommends approval to ensure the company has an equity incentive vehicle aligned with its growth objectives.

This procedural management proposal asks stockholders to authorize the Board to adjourn the Annual Meeting, if necessary, to solicit additional proxies to obtain sufficient votes for key proposals (specifically Proposals 1 through 4). The mechanics are straightforward: if votes are not sufficient at the time of the meeting, the Board can delay or reconvene the meeting to continue soliciting support, reducing the need to schedule a separate special meeting or abandon proposals. The Board argues this delegation aids efficient governance and increases the likelihood that strategic matters—such as the Authorized Share Capital increase, reverse split authority, and the 2026 Plan—can be approved with adequate participation. From a stockholder perspective this is a routine but important procedural authorization; it does not change the substance of other proposals but can affect timing and the scope of subsequent solicitations. Risks are limited, though an adjournment could temporarily delay the full implementation of approved actions and may create short-term uncertainty in the trading market. Broker non-votes and abstentions are not counted as votes cast for this majority-of-votes proposal, so actual voting participation will determine whether adjournment is useful. Analysts should note whether management plans to use adjournment to materially expand solicitation efforts or time additional disclosures and should monitor post-meeting proxy activity. The Board recommends approval to preserve flexibility and to ensure that shareholder decisions can be reached with sufficient participation.